Back to Search Start Over

New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.

Authors :
Ersoy, Tunc
Keil, Vera
Hadizadeh, Dariusch
Gielen, Gerrit
Fimmers, Rolf
Waha, Andreas
Heidenreich, Barbara
Kumar, Rajiv
Schild, Hans
Simon, Matthias
Source :
Neuroradiology; Dec2017, Vol. 59 Issue 12, p1223-1231, 9p, 1 Color Photograph, 1 Black and White Photograph, 1 Diagram, 2 Charts
Publication Year :
2017

Abstract

Purpose: Magnetic resonance (MR) imaging biomarkers can assist in the non-invasive assessment of the genetic status in glioblastomas (GBMs). Telomerase reverse transcriptase ( TERT) promoter mutations are associated with a negative prognosis. This study was performed to identify MR imaging biomarkers to forecast the TERT mutation status. Methods: Pre-operative MRIs of 64/67 genetically confirmed primary GBM patients (51/67 TERT-mutated with rs2853669 polymorphism) were analyzed according to Visually AcceSAble Rembrandt Images (VASARI) () imaging criteria by three radiological raters. TERT mutation and O-methylguanine-DNA methyltransferase ( MGMT) hypermethylation data were obtained through direct and pyrosequencing as described in a previous study. Clinical data were derived from a prospectively maintained electronic database. Associations of potential imaging biomarkers and genetic status were assessed by Fisher and Mann-Whitney U tests and stepwise linear regression. Results: No imaging biomarkers could be identified to predict TERT mutational status (alone or in conjunction with TERT promoter polymorphism rs2853669 AA-allele). TERT promoter mutations were more common in patients with tumor-associated seizures as first symptom (26/30 vs. 25/37, p = 0.07); these showed significantly smaller tumors [13.1 (9.0-19.0) vs. 24.0 (16.6-37.5) all cm; p = 0.007] and prolonged median overall survival [17.0 (11.5-28.0) vs. 9.0 (4.0-12.0) all months; p = 0.02]. TERT-mutated GBMs were underrepresented in the extended angularis region ( p = 0.03), whereas MGMT-methylated GBMs were overrepresented in the corpus callosum ( p = 0.03) and underrepresented temporomesially ( p = 0.01). Conclusion: Imaging biomarkers for prediction of TERT mutation status remain weak and cannot be derived from the VASARI protocol. Tumor-associated seizures are less common in TERT mutated glioblastomas. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00283940
Volume :
59
Issue :
12
Database :
Complementary Index
Journal :
Neuroradiology
Publication Type :
Academic Journal
Accession number :
126198187
Full Text :
https://doi.org/10.1007/s00234-017-1920-1